| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.72 | 0.008 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.009 |